RPL23 was found to negatively regulate apoptosis via the RPL23/Miz-1/c-Myc circuit in a higher-risk myelodysplastic syndrome patient cell line [23], and it could promote multidrug resistance in gastric cancer cells by inhibiting drug-induced apoptosis [24]. This evidence concerns the gene MYC and myelodysplastic syndrome.